Initial Therapeutics
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $3.8M
Investors
- 1
About Initial Therapeutics
D. Cate, Spiros Liras (CEO), Brian Paegel, and Kevan Shokat in 2020, Initial Therapeutics, Inc. launched by Apple Tree Partners (ATP), operates as a biotechnology company that focuses on developing small-molecule medicine for difficult-to-drug protein targets to prevent the onset of diseases. The company has developed an approach to disease intervention by targeting specific high-value protein targets using selective termination of protein synthesis (STOPS) in the exit tunnel of the ribosome. By leveraging this platform, STOPS, the company designs small-molecule medicines to halt pathogenic protein formation in the earliest stages.
Who invested in Initial Therapeutics
1 investor across 2 rounds
See all investors in Initial Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Initial Therapeutics
Who invested in Initial Therapeutics?
Initial Therapeutics has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Initial Therapeutics raised?
Initial Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Initial Therapeutics last raise money?
Initial Therapeutics's most recent round on record is a Series A, in Feb 2021.
What does Initial Therapeutics do?
Initial Therapeutics is a biotechnology company.
Where is Initial Therapeutics headquartered?
Initial Therapeutics is headquartered in San Francisco, US.
Which VCs invest in companies like Initial Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Initial Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Initial Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.